Boston Scientific | BSX - Ebit



Boston Scientific reported $942M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Abbott USD 2.07B 105M Jun/2025
AtriCure USD -3820000 2.13M Jun/2025
Avanos Medical USD -53660000 65.46M Jun/2025
Baxter International USD 272M 120M Jun/2025
Becton, Dickinson and Co. USD 979M 379M Jun/2025
Boston Scientific USD 942M 408M Jun/2025
CONMED USD 37.74M 7.6M Jun/2025
Cooper Companies USD 177.3M 72.2M Jul/2025
Danaher USD 760M 939M Jun/2025
Dexcom USD 245.8M 102.7M Jun/2025
Edwards Lifesciences USD 430.9M 19.6M Jun/2025
Globus Medical USD -125953000 224.01M Jun/2025
Hologic USD 263.9M 37.7M Jun/2025
Illumina USD 331M 119M Jun/2025
Insulet USD 121.1M 32.3M Jun/2025
Integra LifeSciences USD -509910000 498.69M Jun/2025
Intuitive Surgical USD 746.9M 20.6M Jun/2025
J&J USD 6.94B 443M Jun/2025
Masimo USD 64.5M 42.4M Jun/2025
Medtronic USD 1.52B 969M Jul/2025
Merit Medical Systems USD 50.15M 18.26M Jun/2025
Stryker USD 1.17B 176M Jun/2025
Tandem Diabetes Care USD -31859000 2.64M Jun/2025
Teleflex USD 156.95M 29.47M Jun/2025
Zimmer Biomet Holdings USD 396.4M 101.2M Jun/2025